Year: 2024
Type: article
Abstract: Pharmacomicrobiomics is an emerging branch of Pharmacology, which deals with effect of variations in microbiome on drug related pharmacokinetics and pharmacodynamics. Gut microbes are of numerous types and millions in numbers. Studying alteration of these microbes and its effect on modifying drugs response and disease prognosis has opened many gateways of treatment in many difficult to treat chronic diseases. Cancer, diabetes mellitus, hypertension, rheumatoid arthritis are certain examples of such diseases. Recent advancement like organ-on-chips and bacterial culturomics may allow pharmacomicrobiomics to completely revolutionize the concept of personalized medicine. Present article is about current and possible future clinical applications of pharmacomicrobiomics.
Authors: Acharya TA, Chhaiya SB, Mehta DS
Institutions: C. U. Shah University, CU Shah Medical College and Hospital
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6911888686
FWCI:
Cites:
Cited by:
Related to: